- Home
- MPLX vs HLN Comparison
MPLX vs HLN Comparison
Compare MPLX & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPLX
- HLN
- Stock Information
- Founded
- MPLX 2012
- HLN 2022
- Country
- MPLX United States
- HLN United Kingdom
- Employees
- MPLX N/A
- HLN N/A
- Industry
- MPLX Oil & Gas Production
- HLN Package Goods/Cosmetics
- Sector
- MPLX Energy
- HLN Consumer Discretionary
- Exchange
- MPLX Nasdaq
- HLN Nasdaq
- Market Cap
- MPLX 54.7B
- HLN 45.6B
- IPO Year
- MPLX 2012
- HLN N/A
- Fundamental
- Price
- MPLX $51.02
- HLN $11.35
- Analyst Decision
- MPLX Buy
- HLN Buy
- Analyst Count
- MPLX 9
- HLN 1
- Target Price
- MPLX $54.33
- HLN $10.95
- AVG Volume (30 Days)
- MPLX 1.4M
- HLN 19.4M
- Earning Date
- MPLX 05-06-2025
- HLN 02-27-2025
- Dividend Yield
- MPLX 7.50%
- HLN 1.48%
- EPS Growth
- MPLX 11.58
- HLN 38.94
- EPS
- MPLX 4.33
- HLN 0.20
- Revenue
- MPLX $11,380,000,000.00
- HLN $14,062,871,660.00
- Revenue This Year
- MPLX $16.90
- HLN $3.63
- Revenue Next Year
- MPLX $4.73
- HLN $4.37
- P/E Ratio
- MPLX $11.78
- HLN $27.81
- Revenue Growth
- MPLX 5.46
- HLN N/A
- 52 Week Low
- MPLX $39.95
- HLN $8.25
- 52 Week High
- MPLX $54.87
- HLN $11.40
- Technical
- Relative Strength Index (RSI)
- MPLX 51.08
- HLN 70.17
- Support Level
- MPLX $50.41
- HLN $11.01
- Resistance Level
- MPLX $51.55
- HLN $11.35
- Average True Range (ATR)
- MPLX 0.89
- HLN 0.13
- MACD
- MPLX 0.05
- HLN 0.04
- Stochastic Oscillator
- MPLX 63.11
- HLN 94.55
About MPLX MPLX LP
MPLX is a partnership that owns both pipelines and gathering and processing assets with extensive holdings in the Appalachian region. The asset base is made up of pipeline assets dropped down from Marathon Petroleum, its sponsor, and gathering and processing assets from MarkWest, which it acquired in 2015. MPLX also acquired Andeavor Logistics in 2019.
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.